IO Biotech Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 42
Employees
  • Stock Symbol
  • IOBT
Stock Symbol
  • Share Price
  • $4.21
  • (As of Monday Closing)

IO Biotech General Information

Description

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Contact Information

Website
www.iobiotech.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark
+45 21 00 00 00

IO Biotech Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IO Biotech Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.21 $6.17 $4.18 - $17.88 $178M 28.8M 35.8K -$6.08

IO Biotech Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2015 31-Dec-2015
Revenue 0 0 0
EBITDA (48,903) (12,016) (10,737)
Net Income (49,124) (12,042) (10,743)
Total Assets 52,038 5,653 9,423
Total Debt 28,276 0 8,663 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IO Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IO Biotech‘s full profile, request access.

Request a free trial

IO Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based
Drug Discovery
Copenhagen, Denmark
42 As of 2022
00000
00000000 00000

00000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

te velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IO Biotech Competitors (57)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
00000 00000000000 Venture Capital-Backed Lyngby, Denmark 0 000.00 00000000000 000.00
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
0000000 0000000000 Venture Capital-Backed Maastricht, Netherlands 00 000.00 0000000000 000.00
You’re viewing 5 of 57 competitors. Get the full list »

IO Biotech Patents

  • 45

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

IO Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019378076-A1 Immunogenic arginase 2 polypeptides Pending 14-Nov-2018 00000000
CA-3118794-A1 Immunogenic arginase 2 polypeptides Pending 14-Nov-2018 00000000
EP-3880225-A1 Immunogenic arginase 2 polypeptides Pending 14-Nov-2018 00000000
GB-201818576-D0 Arginase 2 polypeptides Ceased 14-Nov-2018 00000000
AU-2019350356-A1 Arginase1 polypeptides Pending 24-Sep-2018 C12N9/78
To view IO Biotech’s complete patent history, request access »

IO Biotech Executive Team (10)

Name Title Board Seat Contact Info
Mai-Britt Zocca Ph.D Co-Founder, Chief Executive Officer & Board Member
Keith Vendola MD Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Bo Anders Ljungqvist Co-Founder & CMC
Inge Svane Ph.D Co-Founder & Clinical Advisor
Mads Andersen Ph.D Co-Founder & Board Member
You’re viewing 5 of 10 executive team members. Get the full list »

IO Biotech Board Members (14)

Name Representing Role Since
Christian Elling Ph.D Lundbeckfonden Board Member 000 0000
Claus Andersson Ph.D Sunstone Life Science Ventures Board Member 000 0000
David Smith Self Board Member 000 0000
Emmanuelle Coutanceau Ph.D Self Board Member 000 0000
Jack Nielsen Vivo Capital Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

IO Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial